Catherine A. Fabian

Statistics

Publications

Citations

269

H-Index

Active since

2017

Affiliations

The Ohio State University(Current)

Catherine A. Fabian is an author at The Ohio State University specializing in molecular oncology, bruton's tyrosine kinase inhibitors, and bruton tyrosine kinase.

Publications per year

2017–2018

Publications

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Sean D. Reiff, Rose Mantel, Lisa L. Smith et al. · Cancer Discovery · 2018 · 170 citations · Full text

Medicine, Oncology, Pharmacology +17

Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL

Sean D. Reiff, Elizabeth M. Muhowski, Daphne Guinn et al. · Blood · 2018 · 64 citations · Full text

Medicine, Oncology, Pharmacology +15

Abstract 1207: SNS-062 demonstrates efficacy in chronic lymphocytic leukemia <i>in vitro</i> and inhibits C481S mutated Bruton tyrosine kinase

Catherine A. Fabian, Sean D. Reiff, Daphne Guinn et al. · Cancer Research · 2017 · 19 citations

Life Sciences, Cell Biology, Hematology +17

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

Daphne Guinn, Amy Lehman, Catherine A. Fabian et al. · Cancer Medicine · 2017 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–4 of 4